This is further supported by the finding that mutations in membrane-bound O-acyltransferase 7 (MBOAT7), an enzyme that diversifies the fatty acid composition of PI, have been associated with severe liver disease, including increased risk for hepatic steatosis, liver damage, hepatic fibrosis and liver cancer (reviewed in 33). The gene discussed is MBOAT7; the disease is liver disorder.